Enhancing Renal Replacement Therapy: Fresenius MultiFiltrate Acute Therapy System
Introducing the Fresenius MultiFiltrate Acute Therapy System: your comprehensive solution for continuous renal replacement therapy (CRRT). Designed with ease of operation and therapy flexibility in mind, the multiFiltrate system serves as your reliable partner in managing acute kidney injury and renal failure. Whether in the intensive care unit or other clinical settings, the multiFiltrate product range offers a variety of kits tailored to meet diverse therapeutic needs.
One of the key strengths of the multiFiltrate system lies in its versatility, accommodating various CRRT modalities to suit individual patient requirements. From Continuous Veno-Venous Hemofiltration (CVVH) to CVVHDF (Continuous Veno-Venous Hemodiafiltration), the system covers a wide spectrum of treatment options, ensuring optimal therapy delivery across different patient populations.
A standout feature of the multiFiltrate system is its user-friendly operating concept, characterized by self-explanatory menu guides. This intuitive interface simplifies device navigation, allowing healthcare providers to focus more on patient care and less on technical complexities. Moreover, the fully-integrated citrate anticoagulation management sets the system apart by enabling extended dialysis sessions without the need for heparin, enhancing patient safety and treatment efficiency.
In addition to standard CRRT modalities, the multiFiltrate system offers specialized therapy options for pediatric intensive care units. With dedicated paediatric CVVHD and CVVH modes, even the smallest patients can receive safe and effective treatment. Reduced-volume disposables and adapted treatment settings ensure precise therapy delivery while minimizing the risk of complications in pediatric populations.
With its comprehensive range of therapy options, user-friendly interface, and specialized pediatric capabilities, the Fresenius MultiFiltrate Acute Therapy System stands as a reliable and versatile solution for continuous renal replacement therapy. From adult patients in critical care settings to pediatric populations requiring specialized care, the multiFiltrate system provides tailored therapy delivery to meet the unique needs of each individual, ensuring optimal outcomes and patient safety.
For patients at high risk of bleeding complications, especially in critical care scenarios, controlled regional citrate anticoagulation emerges as an optimal solution. The multiFiltrate Ci-Ca therapy, integrated within the system, ensures precise management of citrate anticoagulation, offering several distinct advantages over traditional systemic anticoagulation methods such as heparinization.
One of the primary benefits of multiFiltrate Ci-Ca therapy is the significantly reduced risk of bleeding complications compared to systemic anticoagulation procedures. By locally administering citrate, the system minimizes the systemic effects associated with traditional anticoagulants, thereby enhancing patient safety during treatment.
Furthermore, multiFiltrate Ci-Ca therapy facilitates balanced calcium levels by coupling calcium flow to filtrate flow. This mechanism ensures that the patient's calcium balance is maintained within a healthy range, reducing the risk of hypocalcemia or hypercalcemia, which are common concerns in renal replacement therapy.
Additionally, the therapy allows for targeted control of the acid-base status, contributing to the overall stability of the patient's physiological parameters during treatment. By managing citrate administration in response to extracorporeal blood flow, multiFiltrate Ci-Ca therapy ensures dependable control of anticoagulation. This automatic coupling enhances treatment efficacy while minimizing the risk of clotting events, leading to fewer treatment interruptions and improved patient outcomes.
Moreover, the integration of the EMiC2 filter with Ci-Ca therapy enables enhanced clearance of middle molecules, further optimizing the therapeutic benefits of the multiFiltrate system. With automatic flow balancing in accordance with citrate and calcium infusions, the system offers a seamless and efficient approach to venovenous renal replacement therapy, making it truly effective and continuous in its delivery of care.
